Fenolestrar
Filtrerade sökresultat
OBA-09, MedChemExpress
MedChemExpress OBA-09, a simple ester of pyruvate and salicylic acid, is potent multi-modal neuroprotectant. OBA-09 has anti-oxidative and anti-inflammatory effects.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C10H8O5 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 208.17 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 100 mg/mL (480.38 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 856095-68-6 |
| LEDER | O=C(O)C1=CC=CC=C1OC(C(C)=O)=O |
| Molekylvikt (g/mol) | 208.17 |
| Kemiskt namn eller material | OBA-09 |
| Procent renhet | 99.86% |
| För användning med (applikation) | Neuroscience-Neurodegeneration |
Urolithin A, MedChemExpress
MedChemExpress Urolithin A, a gut-microbial metabolite of ellagic acid, exerts anti-inflammatory, antiproliferative, and antioxidant properties. Urolithin A induces autophagy and apoptosis, suppresses cell cycle progression, and inhibits DNA synthesis.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C13H8O4 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 228.2 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H302 |
| Löslighetsinformation | DMSO : 30 mg/mL (131.46 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Light Yellow |
| CAS | 1143-70-0 |
| LEDER | O=C1C2=CC(O)=CC=C2C3=CC=C(O)C=C3O1 |
| Molekylvikt (g/mol) | 228.2 |
| Kemiskt namn eller material | Urolithin A |
| Procent renhet | 95.57% |
| För användning med (applikation) | Cancer-programmed cell death |
Remetinostat, MedChemExpress
MedChemExpress Remetinostat (SHP-141) is a hydroxamic acid-based inhibitor of histone deacetylase enzymes (HDAC) which is under development for the treatment of cutaneous T-cell lymphoma.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C16H21NO6 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 323.34 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 150 mg/mL (463.91 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 946150-57-8 |
| LEDER | O=C(OC)C1=CC=C(OC(CCCCCCC(NO)=O)=O)C=C1 |
| Molekylvikt (g/mol) | 323.34 |
| Synonym | SHP-141 |
| Kemiskt namn eller material | Remetinostat |
| Procent renhet | 98.0% |
| För användning med (applikation) | Cancer-programmed cell death |
Oxyphenisatin acetate, MedChemExpress
MedChemExpress Oxyphenisatin acetate, the pro-drug of oxyphenisatin, is used to be a laxative.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C24H19NO5 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 401.41 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 100 mg/mL (249.12 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Powder |
| Kvalitet | Research |
| Färg | White |
| CAS | 115-33-3 |
| LEDER | O=C1NC2=C(C=CC=C2)C1(C3=CC=C(OC(C)=O)C=C3)C4=CC=C(OC(C)=O)C=C4 |
| Molekylvikt (g/mol) | 401.41 |
| Kemiskt namn eller material | Oxyphenisatin acetate |
| Procent renhet | 98.0% |
| För användning med (applikation) | Cancer-Kinase/protease |
Guacetisal, MedChemExpress
MedChemExpress Guacetisal is obtained from the esterification of acetylsalicylic acid with guaiacol which has the potential for chronic bronchitis treatment extracted from patent CN 106866420 A.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C16H14O5 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 286.28 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 100 mg/mL (349.31 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 55482-89-8 |
| LEDER | O=C(OC1=CC=CC=C1OC)C2=CC=CC=C2OC(C)=O |
| Molekylvikt (g/mol) | 286.28 |
| Kemiskt namn eller material | Guacetisal |
| Procent renhet | 99.95% |
| För användning med (applikation) | COVID-19-immunoregulation |
Palomid 529, MedChemExpress
MedChemExpress Palomid 529 is a potent inhibitor of mTORC1 and mTORC2 complexes.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C24H22O6 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 406.43 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H301 |
| Löslighetsinformation | DMSO : 100 mg/mL (246.04 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 914913-88-5 |
| LEDER | COC1=C(OCC2=CC=C(C=C2)OC)C=C3C(C4=C(C(O3)=O)C=C(C(C)O)C=C4)=C1 |
| Molekylvikt (g/mol) | 406.43 |
| Synonym | P529 |
| Kemiskt namn eller material | Palomid 529 |
| Procent renhet | 97.0% |
| För användning med (applikation) | Cancer-Kinase/protease |
Otenaproxesul, MedChemExpress
MedChemExpress Otenaproxesul (ATB-346), an orally active non-steroidal anti-inflammatory drug (NSAID), inhibits cyclooxygenase-1 and 2 (COX-1 and 2). Otenaproxesul possesses antiinflammatory and antinociceptive activities.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C21H19NO3S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 365.45 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H315∣H319∣H335 |
| Löslighetsinformation | DMSO : ≥ 51.6 mg/mL (141.20 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Yellow |
| CAS | 1226895-20-0 |
| LEDER | COC1=CC=C(C=C(C(C)C(OC2=CC=C(C(N)=S)C=C2)=O)C=C3)C3=C1 |
| Molekylvikt (g/mol) | 365.45 |
| Synonym | ATB-346 |
| Kemiskt namn eller material | Otenaproxesul |
| Procent renhet | 98.35% |
| För användning med (applikation) | COVID-19-immunoregulation |
BTB06584, MedChemExpress
MedChemExpress BTB06584 is a selective and IF1-dependent mitochondrial F1Fo-ATPase inhibitor without compromising ATP synthesis. BTB06584 can delays ischaemic cell death.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C19H12ClNO6S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 417.82 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H318 |
| Löslighetsinformation | DMSO : ≥ 47 mg/mL (112.49 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 219793-45-0 |
| LEDER | ClC1=CC=C(C(OC2=C([N+]([O-])=O)C=CC(S(C3=CC=CC=C3)(=O)=O)=C2)=O)C=C1 |
| Molekylvikt (g/mol) | 417.82 |
| Kemiskt namn eller material | BTB06584 |
| Procent renhet | 99.83% |
| För användning med (applikation) | Cancer-programmed cell death |
TG 100801, MedChemExpress
MedChemExpress TG 100801 is a prodrug that generates TG 100572 by de-esterification in development to treat age-related macular degeneration. TG 100572 is a multi-targeted kinase inhibitor which inhibits receptor tyrosine kinases and Src kinases; has IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.1, 0.4, 1, 0.2 for VEGFR1, VEGFR2, FGFR1, FGFR2, PDGFRβ, Fgr, Fyn, Hck, Lck, Lyn, Src, Yes, respectively.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C33H30ClN5O3 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 580.08 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 5.56 mg/mL (9.58 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Red |
| CAS | 867331-82-6 |
| LEDER | O=C(C1=CC=CC=C1)OC2=CC=C(Cl)C(C3=CC(C)=C(N=C(NC(C=C4)=CC=C4OCCN5CCCC5)N=N6)C6=C3)=C2 |
| Molekylvikt (g/mol) | 580.08 |
| Kemiskt namn eller material | TG 100801 |
| Procent renhet | 95.0% |
| För användning med (applikation) | Cancer-Kinase/protease |
Dipyrocetyl, MedChemExpress
MedChemExpress Dipyrocetyl is an anti-inflammatory and analgesic agent extracted from patent WO 2011132171 A1.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Vitamin K4, MedChemExpress
MedChemExpress Vitamin K4 is a chemically synthesized Vitamin K which plays an important role in the normal blood coagulation system.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C15H14O4 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 258.27 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H318 |
| Löslighetsinformation | DMSO : 100 mg/mL (387.19 mM; Need ultrasonic) ∣H2O : 0.67 mg/mL (2.59 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 573-20-6 |
| LEDER | CC1=CC(OC(C)=O)=C2C=CC=CC2=C1OC(C)=O |
| Molekylvikt (g/mol) | 258.27 |
| Synonym | acetomenaphthone |
| Kemiskt namn eller material | Vitamin K4 |
| Procent renhet | 99.89% |
| För användning med (applikation) | Cancer-programmed cell death |
Resorcinol monoacetate, MedChemExpress
MedChemExpress Resorcinol monoacetate (Acetylresorcinol) is an antiseptic and a disinfectant, is a chemical intermediate for the production of many other pharmaceuticals, and has the potential for acne, seborrheic dermatitis, eczema, psoriasis, and other skin disorders research.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Dihydrocoumarin, MedChemExpress
MedChemExpress Dihydrocoumarin is a compound found in Melilotus officinalis. Dihydrocoumarin is a yeast Sir2p inhibitor. Dihydrocoumarin also inhibits human SIRT1 and SIRT2 with IC50s of 208 μM and 295 μM, respectively.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Coumestrol, MedChemExpress
MedChemExpress Coumestrol, a phytoestrogen present in soybean products, exhibits activities against cancers, neurological disorders, and autoimmune diseases. It suppresses proliferation of ES2 cells with an IC50 of 50 μM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C15H8O5 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 268.22 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H302∣H315∣H319∣H335 |
| Löslighetsinformation | DMSO : 25 mg/mL (93.21 mM; ultrasonic and warming and heat to 60°C) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Light Brown |
| CAS | 479-13-0 |
| LEDER | O=C1C2=C(OC3=CC(O)=CC=C32)C4=CC=C(O)C=C4O1 |
| Molekylvikt (g/mol) | 268.22 |
| Kemiskt namn eller material | Coumestrol |
| Procent renhet | 95.0% |
| För användning med (applikation) | Cancer-Kinase/protease |
SBI-115, MedChemExpress
MedChemExpress SBI-115 is a TGR5 (GPCR19) antagonist. SBI-115 decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C14H13ClN2O4S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 340.78 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 150 mg/mL (440.17 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Off-White |
| CAS | 882366-16-7 |
| LEDER | O=C(C1=NC(S(=O)(CC)=O)=NC=C1Cl)OC2=CC=CC(C)=C2 |
| Molekylvikt (g/mol) | 340.78 |
| Kemiskt namn eller material | SBI-115 |
| Procent renhet | 99.57% |
| För användning med (applikation) | COVID-19-immunoregulation |